サンバイオの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2018/10/15 | 3,705 | 3,730 | 3,610 | 3,670 | -35 | -0.9% | 303,700 |
| 2018/10/12 | 3,535 | 3,725 | 3,510 | 3,705 | +165 | +4.7% | 460,800 |
| 2018/10/11 | 3,375 | 3,620 | 3,355 | 3,540 | -105 | -2.9% | 711,200 |
| 2018/10/10 | 3,690 | 3,720 | 3,595 | 3,645 | -45 | -1.2% | 425,000 |
| 2018/10/09 | 3,610 | 3,745 | 3,530 | 3,690 | +115 | +3.2% | 361,100 |
| 2018/10/05 | 3,665 | 3,725 | 3,540 | 3,575 | -160 | -4.3% | 697,700 |
| 2018/10/04 | 3,795 | 3,865 | 3,640 | 3,735 | -90 | -2.4% | 475,300 |
| 2018/10/03 | 3,655 | 3,855 | 3,640 | 3,825 | +125 | +3.4% | 619,600 |
| 2018/10/02 | 4,000 | 4,010 | 3,690 | 3,700 | -245 | -6.2% | 1,099,100 |
| 2018/10/01 | 3,950 | 4,040 | 3,890 | 3,945 | ±0 | ±0% | 586,100 |
| 2018/09/28 | 4,000 | 4,115 | 3,780 | 3,945 | -55 | -1.4% | 953,500 |
| 2018/09/27 | 3,865 | 4,135 | 3,845 | 4,000 | +190 | +5% | 1,393,400 |
| 2018/09/26 | 3,820 | 3,915 | 3,775 | 3,810 | +25 | +0.7% | 623,800 |
| 2018/09/25 | 3,685 | 3,865 | 3,665 | 3,785 | +105 | +2.9% | 793,700 |
| 2018/09/21 | 3,695 | 3,770 | 3,630 | 3,680 | +115 | +3.2% | 544,100 |
| 2018/09/20 | 3,615 | 3,620 | 3,510 | 3,565 | -85 | -2.3% | 575,900 |
| 2018/09/19 | 3,700 | 3,750 | 3,560 | 3,650 | -145 | -3.8% | 1,013,500 |
| 2018/09/18 | 3,810 | 3,845 | 3,690 | 3,795 | -120 | -3.1% | 462,200 |
| 2018/09/14 | 3,780 | 3,995 | 3,630 | 3,915 | +135 | +3.6% | 824,300 |
| 2018/09/13 | 3,745 | 3,780 | 3,555 | 3,780 | +105 | +2.9% | 428,700 |
| 2018/09/12 | 4,050 | 4,090 | 3,625 | 3,675 | -305 | -7.7% | 952,700 |
| 2018/09/11 | 3,925 | 4,030 | 3,835 | 3,980 | +265 | +7.1% | 975,700 |
| 2018/09/10 | 3,690 | 3,865 | 3,635 | 3,715 | +40 | +1.1% | 529,900 |
| 2018/09/07 | 3,560 | 3,705 | 3,415 | 3,675 | +65 | +1.8% | 598,600 |
| 2018/09/06 | 3,630 | 3,725 | 3,490 | 3,610 | -110 | -3% | 530,400 |
| 2018/09/05 | 3,750 | 3,880 | 3,485 | 3,720 | +25 | +0.7% | 1,161,800 |
| 2018/09/04 | 4,100 | 4,135 | 3,555 | 3,695 | -560 | -13.2% | 2,395,400 |
| 2018/09/03 | 4,300 | 4,385 | 4,145 | 4,255 | +135 | +3.3% | 876,100 |
| 2018/08/31 | 3,890 | 4,230 | 3,855 | 4,120 | +175 | +4.4% | 1,133,800 |
| 2018/08/30 | 3,915 | 3,945 | 3,815 | 3,945 | +105 | +2.7% | 464,500 |
| 2018/08/29 | 3,835 | 3,915 | 3,805 | 3,840 | +50 | +1.3% | 550,500 |
| 2018/08/28 | 3,700 | 3,895 | 3,655 | 3,790 | +170 | +4.7% | 890,500 |
| 2018/08/27 | 3,555 | 3,715 | 3,550 | 3,620 | +180 | +5.2% | 843,000 |
| 2018/08/24 | 3,365 | 3,450 | 3,345 | 3,440 | +100 | +3% | 296,300 |
| 2018/08/23 | 3,395 | 3,465 | 3,300 | 3,340 | -35 | -1% | 520,700 |
| 2018/08/22 | 3,270 | 3,440 | 3,260 | 3,375 | +140 | +4.3% | 732,600 |
| 2018/08/21 | 3,115 | 3,300 | 3,075 | 3,235 | +105 | +3.4% | 600,300 |
| 2018/08/20 | 3,095 | 3,140 | 3,025 | 3,130 | +90 | +3% | 314,500 |
| 2018/08/17 | 2,868 | 3,060 | 2,859 | 3,040 | +222 | +7.9% | 442,400 |
| 2018/08/16 | 2,885 | 2,909 | 2,784 | 2,818 | -87 | -3% | 337,400 |
| 2018/08/15 | 2,958 | 3,025 | 2,840 | 2,905 | -54 | -1.8% | 347,900 |
| 2018/08/14 | 3,000 | 3,055 | 2,951 | 2,959 | -11 | -0.4% | 205,100 |
| 2018/08/13 | 3,075 | 3,100 | 2,968 | 2,970 | -110 | -3.6% | 265,500 |
| 2018/08/10 | 3,120 | 3,160 | 3,060 | 3,080 | -40 | -1.3% | 187,400 |
| 2018/08/09 | 3,070 | 3,150 | 3,025 | 3,120 | +35 | +1.1% | 177,700 |
| 2018/08/08 | 2,995 | 3,120 | 2,995 | 3,085 | +98 | +3.3% | 223,200 |
| 2018/08/07 | 3,020 | 3,070 | 2,956 | 2,987 | -38 | -1.3% | 247,700 |
| 2018/08/06 | 3,135 | 3,150 | 3,025 | 3,025 | -115 | -3.7% | 337,800 |
| 2018/08/03 | 3,025 | 3,175 | 3,005 | 3,140 | +125 | +4.1% | 482,500 |
| 2018/08/02 | 3,000 | 3,060 | 2,971 | 3,015 | -15 | -0.5% | 193,100 |
1601～
1650
件表示中 / 2464件
類似銘柄と比較する
現在ご覧いただいている「サンバイオ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| サンバイオ | 240,900円 | - | - | 0.00% | - | 111.58倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
| 鳥居薬 | 633,000円 | +7.1% | -35.0% | 0.00% | 52.34倍 | 1.46倍 |
|
ＪＴ傘下。柱の抗ＨＩＶ薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
| 科研薬 | 386,700円 | +30.5% | +111.0% | 4.91% | 10.90倍 | 0.95倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の２本柱。後発品も展開 |
| 東和薬品 | 261,300円 | +13.9% | +6.6% | 2.68% | 6.81倍 | 0.81倍 |
|
後発医薬品メーカーで国内２強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
| ジーエヌアイ | 237,400円 | +21.7% | +999.9% | 0.00% | 9.89倍 | 3.27倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
市場注目の銘柄
チャート関連のコラム
